BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 29626376)

  • 1. LI-RADS 2017: An update.
    Kielar AZ; Chernyak V; Bashir MR; Do RK; Fowler KJ; Mitchell DG; Cerny M; Elsayes KM; Santillan C; Kamaya A; Kono Y; Sirlin CB; Tang A
    J Magn Reson Imaging; 2018 Jun; 47(6):1459-1474. PubMed ID: 29626376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of Liver Imaging Reporting and Data System 2017 (LI-RADS) Criteria for Imaging Diagnosis of Hepatocellular Carcinoma.
    Kierans AS; Makkar J; Guniganti P; Cornman-Homonoff J; Lee MJ; Pittman M; Askin G; Hecht EM
    J Magn Reson Imaging; 2019 Jun; 49(7):e205-e215. PubMed ID: 30257054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LI-RADS
    Chernyak V; Tang A; Flusberg M; Papadatos D; Bijan B; Kono Y; Santillan C
    Abdom Radiol (NY); 2018 Jan; 43(1):82-100. PubMed ID: 28647768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of contrast-enhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS.
    Schellhaas B; Görtz RS; Pfeifer L; Kielisch C; Neurath MF; Strobel D
    Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1036-1044. PubMed ID: 28562394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LI-RADS
    Chernyak V; Santillan CS; Papadatos D; Sirlin CB
    Abdom Radiol (NY); 2018 Jan; 43(1):111-126. PubMed ID: 28695233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. User and system pitfalls in liver imaging with LI-RADS.
    Elsayes KM; Fowler KJ; Chernyak V; Elmohr MM; Kielar AZ; Hecht E; Bashir MR; Furlan A; Sirlin CB
    J Magn Reson Imaging; 2019 Dec; 50(6):1673-1686. PubMed ID: 31215119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver imaging reporting and data system (LI-RADS) version 2014: understanding and application of the diagnostic algorithm.
    An C; Rakhmonova G; Choi JY; Kim MJ
    Clin Mol Hepatol; 2016 Jun; 22(2):296-307. PubMed ID: 27304548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LI-RADS Version 2018 Ancillary Features at MRI.
    Cerny M; Chernyak V; Olivié D; Billiard JS; Murphy-Lavallée J; Kielar AZ; Elsayes KM; Bourque L; Hooker JC; Sirlin CB; Tang A
    Radiographics; 2018; 38(7):1973-2001. PubMed ID: 30289735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular carcinoma (HCC) versus non-HCC: accuracy and reliability of Liver Imaging Reporting and Data System v2018.
    Ludwig DR; Fraum TJ; Cannella R; Ballard DH; Tsai R; Naeem M; LeBlanc M; Salter A; Tsung A; Shetty AS; Borhani AA; Furlan A; Fowler KJ
    Abdom Radiol (NY); 2019 Jun; 44(6):2116-2132. PubMed ID: 30798397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LI-RADS major features: CT, MRI with extracellular agents, and MRI with hepatobiliary agents.
    Santillan C; Fowler K; Kono Y; Chernyak V
    Abdom Radiol (NY); 2018 Jan; 43(1):75-81. PubMed ID: 28828680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast-enhanced ultrasound (CEUS) liver imaging reporting and data system (LI-RADS) 2017 - a review of important differences compared to the CT/MRI system.
    Kim TK; Noh SY; Wilson SR; Kono Y; Piscaglia F; Jang HJ; Lyshchik A; Dietrich CF; Willmann JK; Vezeridis A; Sirlin CB
    Clin Mol Hepatol; 2017 Dec; 23(4):280-289. PubMed ID: 28911220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence Supporting LI-RADS Major Features for CT- and MR Imaging-based Diagnosis of Hepatocellular Carcinoma: A Systematic Review.
    Tang A; Bashir MR; Corwin MT; Cruite I; Dietrich CF; Do RKG; Ehman EC; Fowler KJ; Hussain HK; Jha RC; Karam AR; Mamidipalli A; Marks RM; Mitchell DG; Morgan TA; Ohliger MA; Shah A; Vu KN; Sirlin CB;
    Radiology; 2018 Jan; 286(1):29-48. PubMed ID: 29166245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LI-RADS categories: concepts, definitions, and criteria.
    Santillan C; Chernyak V; Sirlin C
    Abdom Radiol (NY); 2018 Jan; 43(1):101-110. PubMed ID: 29038857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma: Can LI-RADS v2017 with gadoxetic-acid enhancement magnetic resonance and diffusion-weighted imaging improve diagnostic accuracy?
    Zhang T; Huang ZX; Wei Y; Jiang HY; Chen J; Liu XJ; Cao LK; Duan T; He XP; Xia CC; Song B
    World J Gastroenterol; 2019 Feb; 25(5):622-631. PubMed ID: 30774276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.
    Terzi E; Iavarone M; Pompili M; Veronese L; Cabibbo G; Fraquelli M; Riccardi L; De Bonis L; Sangiovanni A; Leoni S; Zocco MA; Rossi S; Alessi N; Wilson SR; Piscaglia F;
    J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver Imaging Reporting and Data System (LI-RADS) v2018: Review of the CT/MRI Diagnostic Categories.
    Kanmaniraja D; Dellacerra G; Holder J; Erlichman D; Chernyak V
    Can Assoc Radiol J; 2021 Feb; 72(1):142-149. PubMed ID: 32063008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interobserver and intermodality agreement of standardized algorithms for non-invasive diagnosis of hepatocellular carcinoma in high-risk patients: CEUS-LI-RADS versus MRI-LI-RADS.
    Schellhaas B; Hammon M; Strobel D; Pfeifer L; Kielisch C; Goertz RS; Cavallaro A; Janka R; Neurath MF; Uder M; Seuss H
    Eur Radiol; 2018 Oct; 28(10):4254-4264. PubMed ID: 29675659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on the Liver Imaging Reporting and Data System: What the Pathologist Needs to Know.
    Tang A; Valasek MA; Sirlin CB
    Adv Anat Pathol; 2015 Sep; 22(5):314-22. PubMed ID: 26262514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LI-RADS-CEUS - Proposal for a Contrast-Enhanced Ultrasound Algorithm for the Diagnosis of Hepatocellular Carcinoma in High-Risk Populations.
    Schellhaas B; Wildner D; Pfeifer L; Goertz RS; Hagel A; Neurath MF; Strobel D
    Ultraschall Med; 2016 Dec; 37(6):627-634. PubMed ID: 27486793
    [No Abstract]   [Full Text] [Related]  

  • 20. Diagnostic performance of MR for hepatocellular carcinoma based on LI-RADS v2018, compared with v2017.
    Ren AH; Zhao PF; Yang DW; Du JB; Wang ZC; Yang ZH
    J Magn Reson Imaging; 2019 Sep; 50(3):746-755. PubMed ID: 30648327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.